Christopher R. Gordon

Insider Reports History

Entity: Individual
Location: C/O Bain Capital, Llc, John Hancock Tower, 200 Clarendon Street, Boston, MA
Signature: /s/ Chris Gordon
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher R. Gordon:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Cerevel Therapeutics Holdings, Inc.	Director, 10%+ Owner	Common Stock	0	$0	$41.18	Aug 1, 2024	Direct
Cerevel Therapeutics Holdings, Inc.	Director, 10%+ Owner	Common Stock	0	$0	$41.18	Aug 1, 2024	Indirect
KESTRA MEDICAL TECHNOLOGIES, LTD.	Director, 10%+ Owner	Common Shares	27M			Mar 6, 2025	Indirect
Cerevel Therapeutics Holdings, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	0			Aug 1, 2024	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Christopher R. Gordon

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
KMTS	KESTRA MEDICAL TECHNOLOGIES, LTD.	Mar 6, 2025	0	$0	3	Mar 6, 2025	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 1, 2024	4	$0	4	Aug 5, 2024	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 5, 2024	1	$0	4	Jun 7, 2024	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Oct 16, 2023	1	$125M	4	Oct 18, 2023	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 7, 2023	3	$0	4	Jun 9, 2023	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 14, 2022	1	$0	4	Jun 16, 2022	Director, 10%+ Owner
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 10, 2021	1	$0	4	Jun 14, 2021	Director, 10%+ Owner